Serum levels of soluble interleukin-2 receptor and soluble tumor necrosis factor receptor in patients with esophageal carcinoma

Diseases of the Esophagus

Volumn 9, Issue 3, 1996, Pages 202-206

  Jablonska, E ^a   Pietruska, Z ^a   Kozlowski, M ^a   Furman, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 2 RECEPTOR; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; HUMAN; PRIORITY JOURNAL;

EID: 0029811912     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J 1991; 5:2567-25674.
2. Mohler K M, Torrance D S, Smith C A et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endoxemia and function simultaneously as both TNF carries and TNF antagonists. J Immunol 1993; 151: 1548-1561.
3. Tartaglia L A, Weber R F, Figari I S, Reynolds C, Palladino M A, Goeddel D V. The two receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci 1991; 88: 9292-9297.
4. Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cell 1991; 3: 471-479.
5. Anuds T, Gross V, Holstege A et al. High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology 1992;16:749-755.
6. Rubin L A, Kurman C C, Fritz M E, Biddison W E, Boulin B, Yarchoan R. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172-3177.
7. Bemelmans M H A, Gouma D J, Buurman W A. LPS-induced sTNF-receptor release in vivo in a murine model. J Immol 1993; 151:5554-5562.
8. Higuchi M, Aggarwal B B. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 1994; 124:3550-3557.
9. Barton P J, Blanchard D K, Michelini-Norris B, Nicosia S V, Cavanagh D, Djeu J Y. High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood 1993; 83:424-429.
10. Heller R A, Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994; 126:5-9.
11. Gatanga M, Grosen E A, Berger R A, Granger G A, Gatanga T. Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitro. Lymphokine Cytokine Res 1993; 12:249-253.
12. Danieli M G, Paoleti P, Recchioni A, Gabrielli A, Danieli G. Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. Scand J Rheumatol 1993; 22:215-219.
13. Lai K N, Ho S. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma. Cancer 1991; 67:2180-2185.
14. Poulakis N, Sarandakou A, Rizos D, Phocas I, Kontozoglou Th, Polyzogopoulos D. Soluble interleukin-2 receptors and other markers in primary lung cancer. Cancer 1991 ; 68: 1045-1049.
15. Jablonska E, Kozlowski M, Pietruska Z, Furman M. Soluble interleukin-2 receptor in serum of patients with esophageal carcinoma. Neoplasma 1994; 6:315-318.
16. Pusztai L, Clover L M, Cooper K, Starkey P M, Lewis C E, McGee J O. Expression of tumor necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 1994; 70: 289-292.
17. Kniep E M, Strelow I, Lohmann-Matthes M L. The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes. Immunology 1992; 75:299-304.
18. Porteu F, Brockhaus M, Wallach D, Engelman H, Nathan C F. Human neutrophil elastase releases a ligand-binding fragment from 75-kDa tumor necrosis factor (TF) receptor. J Biol Chem 1991;266:18846-18853.
19. Advani S H, Kutz P M, Gopal R et al. Immunity in esophageal carcinoma. J Surg Oncol 1983; 24:268-273.
20. Tsutsui S H, Morita M, Kuwano H, Matsuda H, Mori M, Okamura S, Sugimahi K. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. J Surg Oncol 1992; 49: 176-181.